GeneralFoot & Ankle/Diabetes

Charcot Foot

General
Intermediate
6 min
High Yield
Charcot neuroarthropathydiabetic neuropathyEichenholtz classificationtotal contact castingmidfoot collapserocker-bottom deformityneuropathic arthropathyoffloading
6:00
Start the timer to simulate exam conditions

CIM Case: Charcot Foot

Clinical Scenario

Patient: 60-year-old female Presentation: Right foot swelling and redness developing over 1 week, minimal pain, has been walking on it, noticed "warm feeling" in foot Relevant history: Type 2 diabetes for 15 years, on oral hypoglycaemics and insulin, HbA1c 9.2% (poorly controlled), peripheral neuropathy diagnosed 5 years ago, bilateral cataracts (diabetic retinopathy), previous left foot ulcer healed with conservative treatment Examination findings:

  • Right midfoot significantly swollen and erythematous
  • Increased warmth compared to left foot (>2°C difference by infrared thermometer)
  • Loss of medial longitudinal arch (early rocker-bottom deformity)
  • Peripheral pulses palpable bilaterally (dorsalis pedis, posterior tibial)
  • Absent protective sensation (10g monofilament negative at all sites)
  • Absent ankle reflexes bilaterally
  • No open wounds or ulceration
  • No purulent discharge
  • Probe to bone not applicable (no wound)
  • Able to weight-bear but with antalgic gait
  • Left foot shows healed plantar ulcer scar

Investigations Provided

Laboratory Results

TestResultNormal RangeInterpretation
Hb118 g/L115-160 g/LNormal
WCC8.2 ×10⁹/L4-11 ×10⁹/LNormal (argues against infection)
Platelets245 ×10⁹/L150-400 ×10⁹/LNormal
ESR18 mm/hr<20 mm/hrNormal
CRP12 mg/L<5 mg/LMildly elevated (can occur in acute Charcot)
HbA1c9.2%<6.5%Poorly controlled diabetes
Fasting glucose11.2 mmol/L3.5-5.5 mmol/LElevated
Creatinine145 μmol/L60-110 μmol/LMildly elevated (diabetic nephropathy)
eGFR48 mL/min>90 mL/minStage 3a CKD
Uric acid0.38 mmol/L0.15-0.45 mmol/LNormal (excludes gout)
Procalcitonin0.1 ng/mL<0.5 ng/mLNormal (argues against bacterial infection)

Imaging

Image 1: Weight-bearing AP and Lateral Foot Radiographs

Radiological features:

  • Fragmentation of the tarsometatarsal (Lisfranc) joints
  • Subluxation at tarsometatarsal articulation
  • Subchondral sclerosis and bone debris
  • Joint effusion with soft tissue swelling
  • Early collapse of medial longitudinal arch
  • No sequestrum or involucrum (favours Charcot over osteomyelitis)
  • No gas in soft tissues

Anatomical location: Midfoot (Brodsky Type 1, Sanders/Frykberg Pattern II)

Image 2: MRI Foot with Gadolinium (if obtained)

MRI findings:

  • Bone marrow oedema in navicular, cuneiforms, and metatarsal bases
  • Periarticular soft tissue oedema
  • Joint effusions at Lisfranc joints
  • No rim-enhancing fluid collection (argues against abscess)
  • No sinus tract
  • Subchondral bone changes without cortical destruction pattern typical of osteomyelitis
  • Ghost sign negative (intact cortex)

Questions & Model Answers

Q

What is the differential diagnosis and how do you distinguish Charcot neuroarthropathy from infection?

Q

Describe the classification systems for Charcot neuroarthropathy.

Q

What is the pathophysiology of Charcot neuroarthropathy?

Q

How would you manage this patient's acute Charcot foot?

Q

The patient presents 2 years later with a rocker-bottom deformity and recurrent plantar ulcer. What are your surgical options?

Q

What is the prognosis and how do you counsel this patient about long-term outcomes?


Key Teaching Points

Pattern Recognition

This pattern suggests Charcot Neuroarthropathy:

  • Diabetic patient with peripheral neuropathy
  • Warm, swollen, erythematous foot
  • Relatively painless (neuropathy)
  • Intact skin (no ulcer or wound)
  • Midfoot involvement
  • Normal or only mildly elevated inflammatory markers
  • Radiographic fragmentation without sequestrum

Distinguish from Osteomyelitis:

FeatureCharcotOsteomyelitis
Skin integrityUsually intactUsually wound/ulcer
Probe to boneN/APositive
WCCNormalElevated
ProcalcitoninNormalElevated
LocationMidfoot most commonUnder ulcer

Critical Management Points

  1. Early diagnosis is key - before significant collapse occurs
  2. Offloading is the mainstay - TCC or non-removable walker
  3. Don't confuse with infection - both can have warmth and erythema
  4. Long treatment duration - 6-12 months offloading
  5. Lifelong surveillance - contralateral foot at risk
  6. Surgery for deformity/ulceration - not primary treatment

Common Examiner Follow-ups

Q: "How do you monitor response to treatment?"

Monitoring parameters:

  • Temperature difference: Should decrease to <2°C
  • Swelling: Progressive reduction
  • Serial X-rays: Transition from fragmentation to coalescence
  • Clinical examination: Resolution of acute signs

Transition to Stage 2 (coalescence) typically takes 3-6 months. This is when gradual weight-bearing can begin.


Q: "What is the evidence for bisphosphonates in Charcot?"

Evidence for bisphosphonates:

  • Theoretical rationale: Reduce osteoclast activity, prevent bone resorption
  • Jude et al. (2001): Pamidronate reduced bone turnover markers
  • Recent trials: Mixed results, no clear clinical benefit demonstrated
  • Current practice: Not routinely used, consider in refractory cases

The mainstay of treatment remains offloading. Bisphosphonates are not standard of care.


Q: "What if MRI shows changes consistent with both Charcot and osteomyelitis?"

This is challenging - "overlap" cases:

  • Charcot with secondary osteomyelitis: Can occur if ulcer develops
  • Ghost sign: Absent bone marrow on T1 with absent cortex suggests osteomyelitis
  • Sinus tract: Strongly suggests osteomyelitis
  • Response to offloading: Charcot improves; osteomyelitis progresses

If doubt:

  • Bone biopsy for culture and histology
  • Consider tagged WBC scan
  • Trial of offloading with close monitoring
  • Multidisciplinary discussion

Q: "How does Charcot affect surgical planning for foot and ankle procedures?"

Considerations:

  • Higher non-union rate - impaired bone healing
  • Higher infection rate - diabetic microvasculature
  • Need for super constructs - extend fixation, use stronger implants
  • Longer healing times - extended non-weight-bearing
  • Risk of triggering Charcot - any surgery can trigger acute Charcot in at-risk feet

Prophylactic measures:

  • Optimise glycaemic control preoperatively
  • Prolonged non-weight-bearing
  • Close monitoring post-surgery
  • Consider protected weight-bearing longer than standard protocols

  • Diabetic Foot Ulcers
  • Osteomyelitis
  • Midfoot Arthrodesis
  • Peripheral Neuropathy
  • Total Contact Casting
  • Diabetic Foot Infections